To study how an increase in axon number influences the number of glial cells in the mammalian optic nerve, we have analyzed a previously described transgenic mouse that expresses the human bcl-2 gene from a neuron-specific enolase promoter.
In these mice, the normal postnatal loss of retinal ganglion cell axons is greatly decreased and, as a consequence, the number of axons in the optic nerve is increased by -80% compared with wild-type mice. Remarkably, the numbers of oligodendrocytes, astrocytes, and microglial ceils are all increased proportionally in the transgenic optic nerve. The increase in oligodendrocytes apparently results from both a decrease in normal oligodendrocyte death and an increase in oligodendrocyte precursor cell proliferation, whereas the increase in astrocytes apparently results from an increase in the proliferation of astrocyte lineage cells. Unexpectedly, the transgene is expressed in oligodendrocytes and astrocytes, but this does not seem to be responsible for the increased numbers of these cells. These findings indicate that developing neurons and glial cells can interact to adjust glial cell numbers appropriately when neuronal numbers are increased. We also show that the expression of the bcl-2 transgene in retinal ganglion cells protects the cell body from programmed cell death when the axon is cut, but it does not protect the isolated axon from Wallerian degeneration, even though the transgene-encoded protein is present in the axon.
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The size of an organism or organ depends primarily on how many ceils it contains. It is not known, however, how cell numbers are controlled or how the proportions of different cell types are determined and maintained. We have studied these problems in the rodent optic nerve, one of the simplest parts of the CNS.
The mammalian optic nerve contains three main types of glial cells: astrocytes, oligodendrocytes, and microglial cells. Astrocytes develop from neuroepithelial cells in the optic stalk, the primordium of the optic nerve. Oligodendrocytes develop from precursor cells that migrate into the nerve (Small et al., 1987) and microglial cells are derived from the hemopoietic system. The nerve also contains the axons of retinal ganglion cells (RGCs), but no intrinsic neurons.
We have been particularly interested in how the number of oligodendrocytes in the rat optic nerve is determined. Because oligodendrocytes are normally postmitotic (Gard and Pfeiffer, 1989; Hardy and Reynolds, 1991) and their precursor cells proliferate extensively (Temple and Raff, 1986 ) their final number depends on how many precursors migrate into the nerve and how many times each divide before differentiating. Programmed cell death (PCD) also plays a major role in controlling oligodendrocyte numbers: at least half of the oli-godendrocytes in the nerve undergo PCD soon after they develop (Barres et al., 1992) . Optic nerve axons influence oligodendrocyte numbers in several ways: they promote precursor cell proliferation (Barres and Raff, 1993) and they promote oligodendrocyte survival (Barres et al., 1993) . Barres et al. (1993) proposed that normal oligodendrocyte death might help match the number of oligodendrocytes to the number of axons requiring myelination, just as normal neuronal death is thought to help match the number of neurons to the number of target cells the neurons innervate (Cowan et al., 1984; Oppenheim, 1991) : they suggested that newly formed oligodendrocytes require a signal(s) from axons to avoid PCD, and only about half manage to receive enough signal to survive.
Here we have studied transgenic mice that express the human bcl-2 gene controlled by a neuron-specific enolase (NSE) promoter.
Because bcl-2 suppresses PCD (Reed, 1994) these mice have increased numbers of various types of neurons, including RGCs (Dubois-Dauphin et al., 1994; Martinou et al., 1994) . We show that these mice have almost twice the normal number of axons in the adult optic nerve, attributable to a decrease in the normal postnatal loss of axons. In addition, the nerves contain approximately twice the number of oligodendrocytes, astrocytes, and microglial cells. The increased number of oligodendrocytes apparently results from both a decrease in oligodendrocyte death and an increase in oligodendrocyte precursor proliferation, whereas the increase in astrocyte numbers apparently results from increased proliferation of astrocytes. We also show that the bcl-2 transgene is expressed in oligodendrocytes and astrocytes, but this is unlikely to be responsible for the increase in glial cell numbers. A second series of micrographs was taken at higher magnification (6350x for PO, PlO, Pi5 nerves; 2900x for adult nerves). The first micrograph of each series was taken at the pial surface, and serial ones were taken across the nerve until the other pial surface was reached.
The micrographs were put together to create a continuous picture, representing a ribbon of tissue from one side of the nerve to the other. We counted the total number of axons in this montage and measured the area of the montage with the drawing tablet. We then calculated the fraction of the nerve area that the montage represented (which was between 5 and 10%) and multiplied this fraction by the number of axons counted to estimate the number of axons in the whole nerve.
We measured the area and circumference of axons in adult nerves using the drawing tablet and a line drawn through the center of the micrographs to sample the axons; only axons crossed by this line were measured. The number of axons measured in each sample was -400. The results from three transgenic nerves and from three wild-type nerves were pooled for comparison.
To count the numbers of each type of glial cell, cells were located at a magnification of 2900X, and then the magnification was increased to 10,000X to examine the cellular ultrastructure. The entire section was systematically scanned for every cell with a visible nucleus. Measurement of DNA. The total amount of DNA in the optic nerve was measured as described previously (Barres ct al., 1992) . Pairs of nerves were dissected by initially cutting behind the eye and then removing the brain with the optic nerves still attached. Both optic nerves were then cut at the chiasm and placed in digestion buffer containing 10 mM Tris HCI, 50 mM EDTA, 0.1% SDS, and 200 pg/ml proteinasc K. The nerves wcrc minced with scissors and incubated at 55°C for 48 hr. After digestion, the final volume was measured and the DNA was assayed with a fluorimetric method (Labarca and Paigen, 1980) that measures the amount of Hoechst 33258 dye that binds to DNA, using a Perkin-Elmer LS-5 luminescence spectrometer (Norwalk, CT). The amount of DNA was translated into cell number by assuming 5.8 pg of DNA per diploid cell (Ausubel et al., 1991 To determine whether the expression of human Bcl-2 in oligodendrocytes could protect them when they are deprived of survival signals in culture, we dissociated P8 optic nerve cells using 0.125% trypsin for 30 min in Earle's balanced salt solution (EBSS; Gibco). After dissociation, the cells were washed in 30% FCS and cultured at low density (10,000 cells per coverslip) in DMEM.
Both wild-type and transgenic cells were mixed together in these cultures so that they were exposed to the same environment.
After 1 and 3 d in culture, cells were stained with a monoclonal anti-galactocerebroside (GC) antibody (ascites fluid diluted 1:lOO in TBLS) (Ranscht et al., 1982) , followed by Texas-Red-coupled goat anti-mouse immunoglobulin (G antiMIg Tex Red; Jackson Laboratories) diluted 1:lOO in TBLS to identify the oligodendrocytes.
The cells were then lixed with methanol and stained with anti-human Bcl-2 as above, except that the antibody was visualized with a class-specific, fluorescein-coupled goat anti-mouse IgGl (G ant-MIgGl Fl; Nordic, Captistrano Beach, CA) diluted 1:50 in TBLS. We then counted the proportion of GC' oligodendrocytes that were Bcl-2+.
Optic nerve transection.
P18 mice were anesthetized using Hypnorm and Diazepam.
The left eye was retracted to allow access to the optic nerve, which was cut with ophthalmology scissors just behind the globe. Successful transection was confirmed by visual inspection when the mouse was killed 4 d later. Frozen sections of the ncrvcs wcrc prcparcd and stained with PI as described above. Some sections were also stained with the RT97 monoclonal anti-neurofilament (diluted 1:500) (Wood and Anderton, 1981) overnight at 4°C followed by G anti-MIg Fl.
Retinal explant cultures.
Neural retinae were removed from adult mice in PBS. The whole retina was placed (pigment layer down) on a polycarbonate filter floating in 10 ml of DMEM in a petri dish at 37°C in 5% CO,. After 4 d, the tissue was fixed in 4% paraformaldehyde in 0.1 M phosphate, cryoprotccted with 1 M sucrose, and 10 pm frozen sections were cut through the nerve head to the periphery of the retina; every third section was saved. The sections were post-fixed with methanol and stained with antiserum against protein gene product 9.5, which is restrictcd to horizontal cells and RGCs in the mammalian retina (Bonfanti et al., lY92 axons of transgenic RGCs as well as in their-cell bodies, small fragments of PO retina wcrc cultured on glass covcrslips coat& with PDL and laminin (5 pg/ml). Explants wcrc grown in B-S medium containing 1% FCS and insulin (10 ~g/ml) at 37°C in 5% CO,. Aftct-3 d, when axons had grown out from the explants, the cultures were stained with anti-human Bcl-2 antibody as described.
RESULTS
The We crossed these mice with C57BL/6J mice and stained retinal cells from each member of the litters used with an anti-human Bcl-2 antibody to identify the transgenic and nontransgenic (wild-type) progeny. As expected, we found that -50% of the progeny expressed the bcl-2 transgene. No cells were stained in C57BLi6J retinae.
Optic nerve axons
To examine the axons in the optic nerve, we prepared photomontages of cross sections from both optic nerves from three adult transgenic mice and three adult wild-type siblings, as described in Materials and Methods. As shown in Table 1 , the average surface area of the optic nerves in transgenic mice was approximately twice that of nerves in wild-type littermates, and the number of axons was -80% greater. The number of axons in wild-type mice is in good agreement with those reported by Williams et al. (1990) for the same strain of mice. The average diameter and area of individual axons, as well as the proportion of the axons that were myelinated, were about the same in transgenic and wild-type optic nerves. The average length of the optic nerves measured in 6-month-old animals also was not significantly different in the two types of mice (4.7 ? 0.3 mm in transgenic mice vs 4.9 t-0.2 mm in wild-type mice, mean ? SEM; n = 10 and 6, respectively).
As shown in Figure 1 , the average number of axons present at birth was a little greater in transgenic optic nerves than in wildtype nerves, but this difference was not statistically significant. As expected, in both cases the numbers of axons decreased postnatally, presumably reflecting the normal death of RGCs, but the decrease was much greater in wild-type nerves than in transgenic nerves.
Optic nerve glial cells
To compare the total numbers of glial cells in the optic nerves of transgenic and wild-type mice, we measured the total amount of DNA in the nerves and divided the values by the amount of DNA per mouse diploid cell. As shown in Figure 2 , there was no significant difference in the total number of cells at embryonic day 17.5 (E17.5) between transgenic and wild-type littermates. There was a small but significant difference at birth, and this difference steadily increased until about P30, when there were almost twice as many cells in transgenic nerves than in wild-type nerves; this difference persisted at P50.
To determine the number of each glial cell type, we examined three pairs of nerves from 3-month-old transgenic mice and three pairs from their wild-type littermates by electron microscopy. We examined two transverse sections from the central third of the nerve, at least 100 pm apart. We counted only those cells within the boundary of the glial limiting membrane, and we did not count endothelial cells. Mature oligodendrocytes and astrocytes were easy to identify ( and astrocytes. We were unable to classify -3% of the cells. As shown in Table 2, there  were approximately twice as many oligodendrocytes, astrocytes, microglial cells, and oligodendrocyte precursor cells in nerves from bcl-2 transgenic mice compared with nerves from their wild-type littermates. There were no obvious differences in glial cell size in the two types of nerves, consistent with the finding that both total cell number and nerve volume were approximately doubled.
Cell death
To compare the amount of glial cell death in transgenic and wild-type optic nerves, we stained serial longitudinal frozen sections of nerves from mice of different ages with PI to identify normal and pyknotic nuclei, and counted the total number of pyknotic nuclei in each nerve. The total numbers of dead cells were significantly lower in transgcnic nerves than in wild-type nerves at P14 and P21, but were not significantly different at P8 or P29 (Fig. 3) .
It has been shown that all cell death in the postnatal rat optic nerve is confined to the oligodendrocyte cell lineage (Barres et al., 1992) . To help determine whether this is also the case in transgenie and wild-type mouse optic nerves, we double-labeled frozen sections of these nerves with PI to identify dead cells and anti-GFAP antibodies to identify astrocytes. None of the dead cells was GFAP+, as shown previously in the rat optic nerve (Barres et al., 1992) . It is possible, however, that astrocytes that undergo PCD lose their GFAP. To test this possibility, we treated optic nerve explants from P7 animals with a high concentration (1 PM) of the protein kinase inhibitor staurosporine for 3 d to induce PCD. Frozen sections were then cut and stained with PI and anti-GFAP antibodies: many pyknotic cells were seen to be brightly GFAP+, indicating that astrocytes do not necessarily lose their GFAP when they undergo PCD. Thus, it is likely that most of the dead cells in the postnatal mouse optic nerve belong to the oligodendrocytc lincagc, and at Icast some of the increase in oligodendrocytc number in the transgcnic optic nerve reflects a decrease in ccl1 death.
Cell proliferation
To compare the numbers of dividing cells in the optic nerves of transgenic and wild-type mice, we injected BrdU into the peritoneum of P8, Pl4, P21, and P2Y mice. One hour later the mice were killed, serial frozen sections of their optic nerves were stained with anti-BrdU antibody, and all the BrdU+ cells in each nerve were counted. As shown in Figure 4 , the numbers of BrdU+ cells were increased in transgenic compared with wild-type nerves at all four ages. Because most of the increase in astrocyte numbers in rodent optic nerve occurs in the first two postnatal weeks [and most of the increase in oligodcndrocyte numbers occurs after this time (Skoff, 1990; Barres et al., lY92) of the labeled cells at later ages would be expected to bc oligodendrocytc precursor ceils. Because astrocytes were increased as much as oligodcndrocytes in adult transgenic optic nerves (see Table 2 ), and astrocytcs seem not to undergo normal ccl1 death in the optic ncrvc, it was cxpectcd that the proliferation of astrocytcs or their precursors would bc grcatcr in transgcnic ncrvcs than in wild-type ncrvcs. To confirm this, WC looked at BrdU incorporation into astrocytcs in PS ncrvcs. WC injcctcd BrdU twice, 2 hr apart, and killed the mice 2 hr after the last injection. In some mice WC labclcd serial frozen sections of optic nerve with anti-BrdU antibody and counted the total number of BrdU ' cells in the nerves (Table 3 ). In others, we prepared cells from the optic ncrvc, cultured them overnight, and double-labeled them for BrdU and GFAP. Although the proportion of BrdU+ cells in transgenic nerves was not very diferent from that in wild-type nerves (data not shown), -30% of the BrdU' cells were GFAP+ in the cultures of transgcnic cells compared with -15% in cultures of wild-type cells (Table 3 ), suggesting that astrocyte proliferation was greater in the transgenie nerves. Moreover, the increased number of total cells in the transgenic nerves compared with wild-type nerves at P5 could be entirely accounted for by the increased number of GFAP+ astrocytes: Figure 2 shows that there were -55,000 more cells in the transgenic nerves at P5 and, if one uses the numbers for the proportions of GFAP+ cells from Table 3 to calculate the total numbers of astrocytes in the nerves at PS, there wcrc -55,000 more astrocytes.
These findings suggest that the difference in astrocytc numbers between transgenic and wild-type optic nerves mainly rcflccts an increase in the proliferation of astrocytes and/or their precursors, whereas the diffcrcncc in oligodendrocyte numbers reflects both a decrease in normal oligodendrocytc death and an increase in oligodendrocytc precursor proliferation. B&2 transgene expression in optic nerve glial cells In the CNS, NSE is thought to bc expressed only in neurons and neuroendocrine cells (Schmechcl and Marangos, 1983) . This is also reported to be the case for bc Z transgenes controlled by an NSE promoter, in which transgenc expression was detected by P-galactosidase staining (Forss-Petter et al., 1990) . To test whether glial cells in the optic nerve of the hcl-2 transgenic mice express the transgene, we stained cells isolated from the optic nerve with an anti-human Bcl-2 monoclonal antibody, together with cell-type-specific antibodies to identify the glial cells. To our surprise, many optic nerve cells isolated from transgenic mice from line 73 expressed the human Bcl-2 protein, including all of the MBP+ oligodendrocytes and almost all of the GFAP+ astrocytes (Table 4) ; none of the cells isolated from wild-type littermates did so. Microglial cells, identified by their Fc receptors (Raff et al., 197Y), and GFAP-flat cells (presumptive meningeal cells) in cultures prepared from transgenic nerves, did not express detectable human Bcl-2, although some microglial cells wcrc weakly stained (data not shown). When frozen sections of adult optic nerves were stained with anti-human Bcl-2 antibody, most of the glial cells in transgenic ncrvcs wcrc weakly lahclcd, as apparently were the axons, whcrcas thcrc ~21s no staining of wild-type nerves (data not shown).
Effect of transgene expression on oligodendrocyte survival in culture To determine whether the expression of the IX/-2 transgcne could protect optic nerve oligodendrocytcs from PCD when cultured without added survival signals, we dissociated cells from P8 optic ncrvc and cultured them at low density in DMEM. Cells derived from wild-type and transgenic animals were cultured together so that their survival could be directly compared in the same environment. After 1 and 3 d, cultures were stained for GC and human Bcl-2. After I d, there were many viable GC+ oligodendrocytes, and 78 + 1% of them were Bcl-2+ (mean ? SEM of 3 cultures), consistent with the fact that 4 of 6 of the mice used to prepare the optic nerve cells expressed the bcl-2 transgene. After 3 d, the great majority of GC' cells were apoptotic, but of those that were alive, 82 t 3% were Bcl-2~'. (mean 5 SEM of 3 cultures). Thus, the expression of the transgene failed to protect oligodendrocytes from PCD in culture in the absence of added survival factors.
Effect of optic nerve transection Normally, when the developing optic nerve is cut behind the eye, RGCs undergo PCD (Snider et al., 1993) , their disconnected axons rapidly degenerate, and oligodcndrocytcs in the nerve die (David et al., 1984) by PCD (Barres et al., 1993) . To determine whether the expression of the hcl-2 transgene in RGCs and oligodcndrocytes protects the cells and axons from these fates after transection, we cut the optic nerve of P18 transgenic and wild-type mice and examined the nerves after 4 d. We stained frozen sections with the RTY7 monoclonal anti-neurofilament antibody (Wood and Anderton, 1981) to visualize the axons, and with PI to identify pyknotic glial cell nuclei. Very few axons were seen in either the wild-type or transgenic-cut nerves, either by RT97 staining or by phase-contrast microscopy (Fig. 5) . Thus, bcl-2 expression in RGCs does not protect their axons from Wallerian degeneration. Moreover, the number of dead glial cells was at least threefold greater in the cut transgenic nerve than in the cut wild-type nerve (Fig. 6) . None of the dead cells was GFAP ' (not shown), consistent with the possibility that they were oligodendrocytes, as shown previously in transected rat optic nerves. Thus, hcl-2 expression in oligodendrocytcs does not appear to protect them from PCD after optic nerve transection.
To confirm the presence of human Bcl-2 in transgenic RGC axons (suggested by the weak staining of axons in frozen sections of adult optic nerves mentioned above), we cultured explants of retina from neonatal transgenic mice and stained the cultures with anti-human Bcl-2 antibody. As shown in Figure 7 , RGC axons were strongly B&2+.
To determine whether the expression of the 1~1-2 transgcnc would protect the soma of RGCs from axotomy-induced PCD, we cultured explants of adult retina from transgenic and wild-type mice and, after 4 d in culture, stained them with an antiserum that labels RGCs. We counted the numbers of RGC somata remaining in the ganglion cell layer of measured lengths of retinal sections and compared them with those in uncultured adult retina. Whereas only 30% of the RGC somata survived in explants of wild-type retina, YO% survived in explants of transgenic retina, indicating that the 1~1-2 transgcnc protects the RGC soma from ~lxotomy-induced PCD, cvcn though it fails to protect the isolated transcctcd axon.
A different B&2 transgenic mouse line To help dctcrminc whcthcr the incrcasc in astrocytcs and oligodcndrocytcs seen in the 1~1-2 transgcnic mouse lint 73 was directly rclatcd to the cxprcssion of the transgcnc in the glial cells themsclvcs (rather than indirectly related to the incrcascd number of axons), WC studied a second transgcnic mouse lint cxprcssing the same transgcnc from the same promoter. In this mouse line, however, the transgene is not expressed in RGCs, and the optic nerves are normal in size (Martinou et al., 1994) . As shown in Figure 8 , the number of glial cells in the optic nerves of these mice was not significantly different from their wild-type littermates at various ages. We also found that there was no significant difference in the total number of dead cells seen at P14, an age when we found a greatly reduced number of dead ceils in optic nerves from line 73 animals compared with wild-type littermates: the total number of PI-stained pyknotic nuclei in P14 transgenic line 71 nerves was 97 ? 13, compared with 90 t 9 in wild-type nerves, (mean 5 SEM of 3 nerves in both cases). Nonetheless, many of the glial cells, including both astrocytes and oligodendrocytes, expressed the human Bcl-2 protein (Table 4) . Although the proportion of glial cells that expressed the transgene was less than in line 71, the amount of Bcl-2 protein expressed in the positive cells was at least as great, if not greater, when quantified in a confocal fluorescence microscope: in human Bcl-2 ' glial cells from the 73 line, the mean number of arbitrary units was 41 -+ 4, whcrcas in human Bcl-2 ' glial cells from the 71 lint, the mean number of arbitrary units was 50.3 t-IO (/I = 25 cells in both cases). In both lines, there were no significant ditfercnccs in the proportions of oligodcndrocytes that expressed human Bcl-2 at P7 and P14 (Table 4) .
DISCUSSION

Axons
We find that optic nerves from the bcl-2 transgenic mouse line 73 (Martinou et al., 1994) contain 80% more axons than wild-type nerves. This is the result of a decrease in the normal postnatal loss of RGC axons: in wild-type optic nerves, 60% of the axons are lost between birth and P14, whereas only 35% are lost in the transgenie nerves.
Interestingly, the expression of the bcl-2 transgcne in RGCs protects the cell body from PCD when the axon is cut, but it Burne et al. l does not protect the isolated axon from Wallerian degeneraet al. (1995) showed that when sympathetic neurons from tion, even though the transgene-encoded Bcl-2 protein is C57BL/6 Wld mutant mice, the axons of which undergo Walpresent in both the axon and the cell body. These results are lerian degeneration more slowly than those from wild-type consistent with other findings that suggest that the mechanisms mice (Perry et al., 1990) , are cultured without nerve growth of PCD and Wallerian degeneration are different. Buckmaster factor (NGF), their cell bodies undergo PCD, whereas their Control of Glial Cel l Numbers J. Neurosci., March 15, 1996, 76(6) neurites remain intact. Moreover, when sympathetic (Garcia et al., 1992) and sensory (Gagliaridini et al., 1994) neurons protected by bcl-2 or the anti-apoptotic viral gene crm A, respectively, are deprived of NGF, the cell bodies survive but the neurites usually do not. In addition, bcl-2 overexpression in a mutant mouse with a progressive motor neuronopathy (the pmn mouse) prevents the loss of motor neuron cell bodies, but not of motor neuron axons, and the progressive weakness and death of the mouse is unaffected (Sagot et al., 1995) .
Oligodendrocytes
We showed previously in the developing rat optic nerve that axons are required for oligodendrocyte survival (Barres et al., 1993) and that 50% of the oligodendrocytes produced in the rat optic nerve usually die within 2-3 d after they develop (Barres et al., 1992) . We suggested that this massive death reflects a competition for axon-dependent survival signals (Barres et al., 1992) . Forcing newly formed oligodendrocytes to compete for limiting amounts of axon-dependent signals may help match the final number of oligodendrocytes to the number of axons requiring myelination (Barres et al., 1993) . A prediction of this hypothesis is that an increase in axon numbers should decrease oligodendrocyte death. Our findings are consistent with this prediction. The number of oligodendrocytes in the transgenic optic nerve is twice that in the wild-type optic nerve, and at least some of the increase results from a decrease in normal oligodendrocyte death. During the second and third postnatal weeks, when oligodendrocyte death would be expected to be maximal (Barres et al., 1992 ) the number of dead cells in transgenic optic nerves is significantly less than in nontransgenic nerves. We showed previously that 90% of the dead cells in the postnatal rat optic nerve are oligodendrocytes and 10% are oligodendrocyte precursor cells (Barres et al., 1993) . Although we have not directly identified the dead cells in the mouse optic nerve, it seems likely that most of them belong to the oligodendrocyte lineage, because none of them express the astrocyte marker GFAP.
Three lines of evidence suggest that the decrease in normal oligodendrocyte death that occurs in the transgenic optic nerve is mainly secondary to the increase in axons, astrocytes, or both, rather than directly related to the expression of the bcl-2 transgene in oligodendrocytes. First, transection of the transgenic nerve at P18 leads to increased glial cell death, which is proportionally even greater than that seen after transection of wild-type nerves. Because none of the dead cells in the cut nerve is GFAP+ and, in the rat, the increased cell death in transected optic nerves is confined to oligodendrocytes (Ban-es et al., 1993) , it seems likely that the increased cell death in the cut mouse optic nerve is also mainly oligodendrocyte death. Thus, the expression of the bcl-2 transgene in oligodendrocytes does not seem to protect them from PCD when they are deprived of axonal signals in viva. Second, when deprived of survival signals in vitro, transgenic oligodendrocytes do not survive better than wildtype oligodendrocytes. Third, a different bcl-2 transgenic mouse line (line 71), in which the transgene is not expressed in RGCs (Martinou et al., 1994) but is expressed in 30% of the oligodendrocytes and 15% of the astrocytes in the optic nerve, has a normal number of optic nerve glial cells (assessed at various ages) and a normal number of dead cells (assessed at P14). Moreover, the proportion of oligodendrocytes expressing the transgene in this line does not increase from P8 to P14, suggesting that expression of the transgene does not confer a selective survival advantage on these oligodendrocytes. Because the amount of human Bcl-2 protein expressed in individual glial cells is at least as great in line 71 as in line 73, it seems unlikely that the expression of the bcl-2 transgene in oligodendrocytes in line 73 protects these cells from normal cell death.
Axons normally promote the proliferation of oligodendrocyte precursor cells in the developing optic nerve (Barres and Raff, 1993) . Two lines of evidence suggest that an increase in oligodendrocyte precursor cell proliferation also contributes to the increase in oligodendrocyte numbers in the optic nerves of transgenie line 73. First, the number of oligodcndrocyte precursor-like cells in the adult optic ncrvcs of thcsc transgenic mice is approximately twice that in wild-type mice. Second, the total number of cells labeled by an injection of BrdU is higher in the transgcnic compared with wild-type optic nerves at P14, P21, and P29, when most of the dividing cells in the nerve would be expected to be oligodendrocyte precursor cells (Barres et al., 1992) . It is unclear whether the increase in oligodendrocyte precursor proliferation is directly related to the increase in axons, astrocytes, or both.
Astrocytes
Astrocytes are increased as much as oligodendrocytes in the transgenic optic nerve. Because astrocytes apparently do not die in the postnatal rodent optic nerve either during development (Barres et al., 1992) or after nerve transection (Barres et al., 1993) , it seems likely that the increase reflects increased proliferation of astrocytes and/or their precursors in the transgenic nerve. Although the proportions of cells synthesizing DNA in the transgenie and wild-type optic ncrvcs at P5 are not very different, twice as many of these cells are GFAP+ astrocytes in overnight cultures of transgenic compared with wild-type nerves, suggesting that proliferation of astrocyte lineage cells is greater in the transgenic nerve at P5. Moreover, there are -55,000 more glial cells in transgenic optic nerves than in wild-type nerves at P5; all of this increase can bc accounted for by the increase in astrocyte numbers. Although the bcl-2 transgene is expressed in almost all of the astrocytes in transgenic optic nerves, it is unlikely that the transgent is directly responsible for their increased proliferation, because overexpression of bcl-2 has not been reported to increase cell proliferation.
It seems more likely that the increase in axons in the transgenic optic nerve is either directly or indirectly responsible for the increased proliferation, a conclusion supported by our own previous finding that there are half as many astrocytes in rat optic nerves that were cut at birth and studied 15 d later, compared with uncut nerves (David et al., 1984) .
Microglia
Microglia also seem to be increased approximately twofold in the transgenic compared with wild-type optic nerves. The mechanism(s) underlying this apparent increase are unknown because little is known about how the number of microglial cells in the nerve is normally controlled. These cells migrate into the developing nerve via the blood vessels and pia-arachnoid, which are presumably increased in the transgenic nerves; this increase by itself might be enough to account for the increase in microglial cells. Because cultured astrocytes produce factors that are mitogenie for cultured microglial cells (Shafit-Zagardo et al., 1993; Lee et al., 1994) , it is also possible that the increase in microglia is secondary to the increase in astrocytes.
Control
of cell numbers It remains a challenge to understand how the number of cells in an organ or organism is determined. Our findings in the bcl-2 transgenic optic nerve provide a glimpse at how complex the mechanisms are likely to be. The finding that the ratios of the axons to the three major glial cell types are maintained in the enlarged transgenic nerve is remarkable. It indicates that the different cell types can interact with one another and with axons to control their proliferation and survival in a coordinated manner to adjust their numbers rather than their size when the number of axons is increased. A similar adjustment occurs when the number of axons is decreased: in an cxtrcme case in which axons fail to enter the optic stalks in the ocuhr veluvdatiorz mouse, glial cells do not develop thcrc and the mice end up without optic nerves (Silver and Robb, 1979) .
